These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Initial United States clinical and pharmacologic evaluation of misonidazole (Ro-07-0582), an hypoxic cell radiosensitizer. Wasserman TH, Phillips TL, Johnson RJ, Gomer CJ, Lawrence GA, Sadee W, Marques RA, Levin VA, VanRaalte G. Int J Radiat Oncol Biol Phys; 1979 Jun; 5(6):775-86. PubMed ID: 227821 [No Abstract] [Full Text] [Related]
8. Misonidazole as a radiosensitizer in the radiotherapy of glioblastomas and oesophageal cancer. Pharmacokinetic and clinical studies. Tamulevicius P, Bamberg M, Scherer E, Streffer C. Br J Radiol; 1981 Apr; 54(640):318-24. PubMed ID: 7013890 [Abstract] [Full Text] [Related]
9. Misonidazole-a drug for trial in radiotherapy and oncology. Dische S, Saunders MI, Flockhart IR, Lee ME, Anderson P. Int J Radiat Oncol Biol Phys; 1979 Jun; 5(6):851-60. PubMed ID: 227822 [No Abstract] [Full Text] [Related]
10. A study of the effect of misonidazole in conjunction with radiotherapy for the treatment of head and neck cancer. MRC working party on misonidazole in head and neck cancer. Br J Radiol; 1984 Jul; 57(679):585-95. PubMed ID: 6329395 [Abstract] [Full Text] [Related]
11. Pilot study of radiotherapy with misonidazole in head and neck cancer. Paterson IC, Dawes PJ, Henk JM, Moore JL. Clin Radiol; 1981 Mar; 32(2):225-9. PubMed ID: 7214840 [Abstract] [Full Text] [Related]
12. [Local administration of radiosensitizer misonidazole]. Otsuka S, Suda K, Yamashita J, Gi H, Oda Y, Takeuchi J, Handa H, Ono K. No To Shinkei; 1983 Mar; 35(3):249-55. PubMed ID: 6687999 [No Abstract] [Full Text] [Related]
16. The role of microsomal enzyme inducers in the reduction of misonidazole neurotoxicity. Jones DH, Bleehen NM, Workman P, Smith NC. Br J Radiol; 1983 Nov; 56(671):865-70. PubMed ID: 6626878 [Abstract] [Full Text] [Related]